Insider Transactions in Q1 2024 at Acumen Pharmaceuticals, Inc. (ABOS)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 19
2024
|
Derek M Meisner Chief Legal Officer & Corp Sec |
SELL
Open market or private sale
|
Direct |
8,933
-7.58%
|
$26,799
$3.48 P/Share
|
|
Jan 19
2024
|
Daniel Joseph O Connell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,200
-2.94%
|
$45,600
$3.47 P/Share
|
|
Jan 18
2024
|
Eric Siemers Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,124
-2.59%
|
$9,372
$3.71 P/Share
|
|
Jan 18
2024
|
Matt Zuga CFO & Chief Business Officer |
SELL
Open market or private sale
|
Direct |
4,242
-1.97%
|
$12,726
$3.7 P/Share
|
|
Jan 18
2024
|
Russell Barton Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,833
-2.84%
|
$8,499
$3.73 P/Share
|
|
Jan 02
2024
|
Matt Zuga CFO & Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
106,000
+32.95%
|
-
|
|
Jan 02
2024
|
Eric Siemers Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
94,000
+43.78%
|
-
|
|
Jan 02
2024
|
Derek M Meisner Chief Legal Officer & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
91,000
+43.58%
|
-
|
|
Jan 02
2024
|
Russell Barton Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
73,000
+42.27%
|
-
|
|
Jan 02
2024
|
Daniel Joseph O Connell Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
401,000
+43.65%
|
-
|